32437347|t|Cholinergic-like neurons carrying PSEN1 E280A mutation from familial Alzheimer's disease reveal intraneuronal sAPPbeta fragments accumulation, hyperphosphorylation of TAU, oxidative stress, apoptosis and Ca2+ dysregulation: Therapeutic implications.
32437347|a|Alzheimer's disease (AD) is a neurodegenerative disorder characterized by progressive memory loss and cognitive disturbance as a consequence of the loss of cholinergic neurons in the brain, neuritic plaques and hyperphosphorylation of TAU protein. Although the underlying mechanisms leading to these events are unclear, mutations in presenilin 1 (PSEN1), e.g., E280A (PSEN1 E280A), are causative factors for autosomal dominant early-onset familial AD (FAD). Despite advances in the understanding of the physiopathology of AD, there are no efficient therapies to date. Limitations in culturing brain-derived live neurons might explain the limited effectiveness of AD research. Here, we show that mesenchymal stromal (stem) cells (MSCs) can be used to model FAD, providing novel opportunities to study cellular mechanisms and to establish therapeutic strategies. Indeed, we cultured MSCs with the FAD mutation PSEN1 E280A and wild-type (WT) PSEN1 from umbilical cords and characterized the transdifferentiation of these cells into cholinergic-like neurons (ChLNs). PSEN1 E280A ChLNs but not WT PSEN1 ChLNs exhibited increased intracellular soluble amyloid precursor protein (sAPPf) fragments and extracellular Abeta42 peptide and TAU phosphorylation (at residues Ser202/Thr205), recapitulating the molecular pathogenesis of FAD caused by mutant PSEN1. Furthermore, PSEN1 E280A ChLNs presented oxidative stress (OS) as evidenced by the oxidation of DJ-1Cys106-SH into DJ-1Cys106-SO3 and the detection of DCF-positive cells and apoptosis markers such as activated pro-apoptosis proteins p53, c-JUN, PUMA and CASPASE-3 and the concomitant loss of the mitochondrial membrane potential and DNA fragmentation. Additionally, mutant ChLNs displayed Ca2+ flux dysregulation and deficient acetylcholinesterase (AChE) activity compared to control ChLNs. Interestingly, the inhibitor JNK SP600125 almost completely blocked TAU phosphorylation. Our findings demonstrate that FAD MSC-derived cholinergic neurons with the PSEN1 E280A mutation provide important clues for the identification of targetable pathological molecules.
32437347	34	39	PSEN1	Gene	5663
32437347	40	45	E280A	ProteinMutation	tmVar:p|SUB|E|280|A;HGVS:p.E280A;VariantGroup:0;CorrespondingGene:5663;RS#:63750231;CorrespondingSpecies:9606;CA#:341491
32437347	69	88	Alzheimer's disease	Disease	MESH:D000544
32437347	167	170	TAU	Gene	4137
32437347	204	208	Ca2+	Chemical	-
32437347	250	269	Alzheimer's disease	Disease	MESH:D000544
32437347	271	273	AD	Disease	MESH:D000544
32437347	280	306	neurodegenerative disorder	Disease	MESH:D019636
32437347	336	347	memory loss	Disease	MESH:D008569
32437347	352	373	cognitive disturbance	Disease	MESH:D003072
32437347	440	456	neuritic plaques	Disease	MESH:D058225
32437347	485	488	TAU	Gene	4137
32437347	583	595	presenilin 1	Gene	5663
32437347	597	602	PSEN1	Gene	5663
32437347	611	616	E280A	ProteinMutation	tmVar:p|SUB|E|280|A;HGVS:p.E280A;VariantGroup:0;CorrespondingGene:5663;RS#:63750231;CorrespondingSpecies:9606;CA#:341491
32437347	618	623	PSEN1	Gene	5663
32437347	624	629	E280A	ProteinMutation	tmVar:p|SUB|E|280|A;HGVS:p.E280A;VariantGroup:0;CorrespondingGene:5663;RS#:63750231;CorrespondingSpecies:9606;CA#:341491
32437347	698	700	AD	Disease	MESH:D000544
32437347	702	705	FAD	Disease	MESH:D000544
32437347	772	774	AD	Disease	MESH:D000544
32437347	913	915	AD	Disease	MESH:D000544
32437347	1006	1009	FAD	Disease	MESH:D000544
32437347	1145	1148	FAD	Disease	MESH:D000544
32437347	1158	1163	PSEN1	Gene	5663
32437347	1164	1169	E280A	ProteinMutation	tmVar:p|SUB|E|280|A;HGVS:p.E280A;VariantGroup:0;CorrespondingGene:5663;RS#:63750231;CorrespondingSpecies:9606;CA#:341491
32437347	1189	1194	PSEN1	Gene	5663
32437347	1313	1318	PSEN1	Gene	5663
32437347	1319	1324	E280A	ProteinMutation	tmVar:p|SUB|E|280|A;HGVS:p.E280A;VariantGroup:0;CorrespondingGene:5663;RS#:63750231;CorrespondingSpecies:9606;CA#:341491
32437347	1342	1347	PSEN1	Gene	5663
32437347	1458	1465	Abeta42	Gene	351
32437347	1478	1481	TAU	Gene	4137
32437347	1572	1575	FAD	Disease	MESH:D000544
32437347	1593	1598	PSEN1	Gene	5663
32437347	1613	1618	PSEN1	Gene	5663
32437347	1619	1624	E280A	ProteinMutation	tmVar:p|SUB|E|280|A;HGVS:p.E280A;VariantGroup:0;CorrespondingGene:5663;RS#:63750231;CorrespondingSpecies:9606;CA#:341491
32437347	1696	1709	DJ-1Cys106-SH	Chemical	-
32437347	1715	1729	DJ-1Cys106-SO3	Chemical	-
32437347	1833	1836	p53	Gene	7157
32437347	1838	1843	c-JUN	Gene	3725
32437347	1845	1849	PUMA	Gene	27113
32437347	1854	1863	CASPASE-3	Gene	836
32437347	1933	1950	DNA fragmentation	Disease	MESH:D012892
32437347	1989	1993	Ca2+	Chemical	-
32437347	2027	2047	acetylcholinesterase	Gene	43
32437347	2049	2053	AChE	Gene	43
32437347	2120	2123	JNK	Gene	5599
32437347	2124	2132	SP600125	Chemical	MESH:C432165
32437347	2159	2162	TAU	Gene	4137
32437347	2210	2213	FAD	Disease	MESH:D000544
32437347	2255	2260	PSEN1	Gene	5663
32437347	2261	2266	E280A	ProteinMutation	tmVar:p|SUB|E|280|A;HGVS:p.E280A;VariantGroup:0;CorrespondingGene:5663;RS#:63750231;CorrespondingSpecies:9606;CA#:341491
32437347	Positive_Correlation	4137	5663
32437347	Association	MESH:D012892	RS#:63750231;HGVS:p.E280A;CorrespondingGene:5663
32437347	Negative_Correlation	MESH:C432165	5599
32437347	Association	MESH:D000544	4137
32437347	Negative_Correlation	MESH:C432165	RS#:63750231;HGVS:p.E280A;CorrespondingGene:5663
32437347	Positive_Correlation	MESH:D000544	RS#:63750231;HGVS:p.E280A;CorrespondingGene:5663
32437347	Positive_Correlation	351	5663
32437347	Association	MESH:D000544	3725
32437347	Association	MESH:D000544	836
32437347	Negative_Correlation	MESH:C432165	4137
32437347	Association	5599	5663
32437347	Association	27113	5663
32437347	Association	5663	7157
32437347	Association	MESH:D000544	5663
32437347	Association	3725	5663
32437347	Association	4137	5599
32437347	Association	MESH:D012892	5663
32437347	Association	MESH:D000544	5663

